Lenvatinib improves anti-PD-1 therapeutic efficacy by promoting vascular normalization via the NRP-1-PDGFRβ complex in hepatocellular carcinoma.
Yang J, Guo Z, Song M, Pan Q, Zhao J, Huang Y, Han Y, Ouyang D, Yang C, Chen H, Di M, Tang Y, Zhu Q, Wang Q, Li Y, He J, Weng D, Xiang T, Xia J.
Yang J, et al.
Front Immunol. 2023 Jul 21;14:1212577. doi: 10.3389/fimmu.2023.1212577. eCollection 2023.
Front Immunol. 2023.
PMID: 37545530
Free PMC article.